• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用浅表化肱动脉作为血管通路为一名常需行血浆置换的重症肌无力患者。

Use of the Superficialized Brachial Artery as Vascular Access for a Patient with Myasthenia Gravis with a Frequent Need for Plasmapheresis.

机构信息

Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan.

Department of Urology, St. Marianna University School of Medicine, Japan.

出版信息

Intern Med. 2024 Aug 15;63(16):2307-2310. doi: 10.2169/internalmedicine.2990-23. Epub 2024 Jan 13.

DOI:10.2169/internalmedicine.2990-23
PMID:38220192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11414371/
Abstract

A 41-year-old woman diagnosed with seronegative myasthenia gravis struggled to maintain remission for a decade, facing crises every 3 months for several years. After repeated apheresis using a non-tunneled non-cuffed central venous dialysis catheter (NTNCC), complications such as catheter-related thrombus in the internal jugular veins and morbid obesity from steroids made the insertion of NTNCC increasingly difficult, leading to consideration of an alternative permanent vascular access (VA) approach. Thus, we created a subcutaneously superficialized brachial artery as the VA, which allowed the patient to undergo safe and uninterrupted apheresis therapy.

摘要

一位 41 岁的女性被诊断患有血清阴性重症肌无力,经过十年的努力才维持缓解状态,但在过去几年中每 3 个月都会面临一次危机。在多次使用无隧道无袖带中心静脉透析导管(NTNCC)进行血浆置换后,该患者出现了一些并发症,如颈内静脉导管相关血栓形成,以及类固醇引起的病态肥胖,这使得 NTNCC 的插入变得越来越困难,因此我们考虑采用另一种永久性血管通路(VA)方法。于是,我们创建了皮下化肱动脉作为 VA,使患者能够安全、不间断地进行血浆置换治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/968c/11414371/6fdc34a757ce/1349-7235-63-2307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/968c/11414371/4b988c1224c9/1349-7235-63-2307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/968c/11414371/6fdc34a757ce/1349-7235-63-2307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/968c/11414371/4b988c1224c9/1349-7235-63-2307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/968c/11414371/6fdc34a757ce/1349-7235-63-2307-g002.jpg

相似文献

1
Use of the Superficialized Brachial Artery as Vascular Access for a Patient with Myasthenia Gravis with a Frequent Need for Plasmapheresis.利用浅表化肱动脉作为血管通路为一名常需行血浆置换的重症肌无力患者。
Intern Med. 2024 Aug 15;63(16):2307-2310. doi: 10.2169/internalmedicine.2990-23. Epub 2024 Jan 13.
2
Treatment of refractory myasthenia gravis by double-filtration plasmapheresis and rituximab: A case series of nine patients and literature review.双重滤过血浆置换和利妥昔单抗治疗难治性重症肌无力:9 例患者的病例系列及文献复习。
J Clin Apher. 2021 Jun;36(3):348-363. doi: 10.1002/jca.21868. Epub 2020 Dec 21.
3
The forearm arteriovenous graft between the brachial artery and the brachial vein as a reliable dialysis vascular access for patients with inadequate superficial veins.肱动脉-贵要静脉前臂动静脉内瘘为前臂可供选择的血管通路,为那些自身浅静脉条件不好的患者提供了可靠的透析血管通路。
J Vasc Surg. 2019 Jul;70(1):199-207.e4. doi: 10.1016/j.jvs.2018.10.101. Epub 2019 Mar 17.
4
Nanomembrane-Based Therapeutic Plasmapheresis after Non-Invasive Ventilation Failure for Treatment of a Patient with Acute Respiratory Distress Syndrome and Myasthenia Gravis: A Case Report.纳米膜基治疗性血浆置换治疗无创通气失败的急性呼吸窘迫综合征合并重症肌无力患者:病例报告。
Blood Purif. 2019;48(4):382-384. doi: 10.1159/000502078. Epub 2019 Jul 29.
5
Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.免疫吸附血浆置换治疗重症全身型重症肌无力
Arch Dis Child. 1993 Aug;69(2):236-8. doi: 10.1136/adc.69.2.236.
6
Benefit of modified plasmapheresis in the management of myasthenia gravis: a case report.改良血浆置换在重症肌无力治疗中的益处:一例病例报告
Niger J Med. 2006 Apr-Jun;15(2):162-4. doi: 10.4314/njm.v15i2.37103.
7
[Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].[开始肾脏替代治疗的通路:透析前的血管和腹膜临时通路]
Nefrologia. 2008;28 Suppl 3:105-12.
8
Late-onset myasthenia gravis successfully treated with local resection of cervical ectopic thymoma.迟发性重症肌无力经颈异位胸腺局部切除术成功治疗。
J Clin Neurosci. 2020 Mar;73:321-323. doi: 10.1016/j.jocn.2019.12.055. Epub 2020 Jan 8.
9
Comparative study of clinical effects between plasma adsorption and double filtration plasmapheresis in patients with myasthenia gravis.血浆吸附与双重过滤血浆置换治疗重症肌无力的临床效果比较研究
Ther Apher. 1997 Nov;1(4):343-7. doi: 10.1111/j.1744-9987.1997.tb00052.x.
10
[Plasmapheresis in patients with myasthenia gravis].[重症肌无力患者的血浆置换]
Nihon Rinsho. 2008 Jun;66(6):1165-71.

本文引用的文献

1
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Recent Treatment of Myasthenia Gravis].[日本内科学会第112届科学会议:教育讲座:重症肌无力的最新治疗]
Nihon Naika Gakkai Zasshi. 2015 Sep;104(9):1953-8.
2
Vascular access for therapeutic plasma exchange.治疗性血浆置换的血管通路
Transfusion. 2018 Feb;58 Suppl 1:580-589. doi: 10.1111/trf.14479.
3
Vascular access for hemodialysis: current perspectives.血液透析的血管通路:当前观点
Int J Nephrol Renovasc Dis. 2014 Jul 8;7:281-94. doi: 10.2147/IJNRD.S46643. eCollection 2014.
4
Health-related quality-of-life and treatment targets in myasthenia gravis.重症肌无力患者与健康相关的生活质量及治疗目标
Muscle Nerve. 2014 Oct;50(4):493-500. doi: 10.1002/mus.24213. Epub 2014 Aug 30.
5
The choice of vascular access for therapeutic apheresis.治疗性血液成分单采的血管通路选择
J Clin Apher. 2012;27(3):153-9. doi: 10.1002/jca.21225. Epub 2012 Apr 26.
6
Vascular access considerations for therapeutic apheresis procedures.治疗性血液成分单采术的血管通路考量
Semin Dial. 2012 Mar-Apr;25(2):140-4. doi: 10.1111/j.1525-139X.2011.01024.x. Epub 2011 Dec 16.
7
Low-density lipoprotein apheresis by membrane differential filtration (cascade filtration) via arteriovenous fistula performed in children with familial hypercholesterolemia.通过动静脉瘘进行膜式差异过滤(级联过滤)对家族性高胆固醇血症患儿进行低密度脂蛋白单采。
Ther Apher Dial. 2010 Feb;14(1):87-92. doi: 10.1111/j.1744-9987.2009.00795.x.
8
Effects of steroids and retinoids on wound healing.类固醇和维甲酸对伤口愈合的影响。
Arch Surg. 2000 Nov;135(11):1265-70. doi: 10.1001/archsurg.135.11.1265.
9
Superficial repositioning of the artery for chronic hemodialysis: indications and prognosis.慢性血液透析动脉的浅表重新定位:适应证与预后
Am J Kidney Dis. 1995 Oct;26(4):602-6. doi: 10.1016/0272-6386(95)90596-0.